RENLITE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RENLITE Trademark

Serial Number: 79316047 • Registration: 6714947

RENLITE is a trademark filed by Biocytogen Pharmaceuticals (Beijing) Co., Ltd. on February 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (12 trademarks)

No.12, Baoshen South Street,

Entity Type: 03

Trademark Details

Filing Date

February 24, 2021

Registration Date

May 3, 2022

Published for Opposition

February 15, 2022

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 25, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 4, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 4, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 3, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
May 3, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Feb 14, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 26, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 26, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 7, 2022 TROA
REFUSAL PROCESSED BY IB
Nov 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 8, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 23, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 31, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 22, 2021 REPR